Cargando…
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1457005/ https://www.ncbi.nlm.nih.gov/pubmed/16671834 http://dx.doi.org/10.1371/journal.pmed.0030176 |
_version_ | 1782127421980409856 |
---|---|
author | Mooijaart, Simon P Berbée, Jimmy F. P van Heemst, Diana Havekes, Louis M de Craen, Anton J. M Slagboom, P. Eline Rensen, Patrick C. N Westendorp, Rudi G. J |
author_facet | Mooijaart, Simon P Berbée, Jimmy F. P van Heemst, Diana Havekes, Louis M de Craen, Anton J. M Slagboom, P. Eline Rensen, Patrick C. N Westendorp, Rudi G. J |
author_sort | Mooijaart, Simon P |
collection | PubMed |
description | BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have been associated with cardiovascular disease, the relation between plasma apoE levels and cardiovascular disease is unknown. METHODS AND FINDINGS: We assessed APOE genotypes, plasma levels of apoE, cardiovascular risk factors, and mortality in a population-based sample of 546 individuals aged 85 y who participated in the Leiden 85-plus Study and were prospectively followed for specific causes of death for 5 y. Participants in the highest tertile of apoE levels suffered a twofold-increased risk of cardiovascular mortality (hazard ratio compared to lowest tertile, 2.08; 95% confidence interval [CI], 1.30 to 3.33). Among the 324 participants with the ɛ3ɛ3 genotype, the hazard from cardiovascular disease was threefold increased (highest versus lowest tertile 3.01; 95% CI 1.60 to 5.66), with similar estimates for men and women. Other causes of death were not increased significantly. Plasma levels of apoE in ɛ3ɛ3 participants were positively correlated with total cholesterol ( p < 0.001), low-density lipoprotein cholesterol ( p < 0.001) and triglycerides ( p < 0.001) and negatively with high-density lipoprotein cholesterol levels ( p = 0.010). Adjustment for plasma lipids did not change the hazard ratios, whereas interaction was absent. The risk associated with high levels of apoE, however, was strongest in participants from the lowest tertile of C-reactive protein (CRP) levels and absent in those from the highest tertile ( p (interaction) < 0.001). Among participants from the lowest tertile of CRP levels, those with a high apoE levels had a significantly steeper increase in CRP than those with low apoE levels ( p = 0.020). Similar cardiovascular mortality risks as in ɛ3ɛ3 participants were found in ɛ2 and ɛ4 carriers. CONCLUSIONS: In old age, high plasma apoE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality, independent of APOE genotype and plasma lipids. |
format | Text |
id | pubmed-1457005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-14570052006-06-19 ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age Mooijaart, Simon P Berbée, Jimmy F. P van Heemst, Diana Havekes, Louis M de Craen, Anton J. M Slagboom, P. Eline Rensen, Patrick C. N Westendorp, Rudi G. J PLoS Med Research Article BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have been associated with cardiovascular disease, the relation between plasma apoE levels and cardiovascular disease is unknown. METHODS AND FINDINGS: We assessed APOE genotypes, plasma levels of apoE, cardiovascular risk factors, and mortality in a population-based sample of 546 individuals aged 85 y who participated in the Leiden 85-plus Study and were prospectively followed for specific causes of death for 5 y. Participants in the highest tertile of apoE levels suffered a twofold-increased risk of cardiovascular mortality (hazard ratio compared to lowest tertile, 2.08; 95% confidence interval [CI], 1.30 to 3.33). Among the 324 participants with the ɛ3ɛ3 genotype, the hazard from cardiovascular disease was threefold increased (highest versus lowest tertile 3.01; 95% CI 1.60 to 5.66), with similar estimates for men and women. Other causes of death were not increased significantly. Plasma levels of apoE in ɛ3ɛ3 participants were positively correlated with total cholesterol ( p < 0.001), low-density lipoprotein cholesterol ( p < 0.001) and triglycerides ( p < 0.001) and negatively with high-density lipoprotein cholesterol levels ( p = 0.010). Adjustment for plasma lipids did not change the hazard ratios, whereas interaction was absent. The risk associated with high levels of apoE, however, was strongest in participants from the lowest tertile of C-reactive protein (CRP) levels and absent in those from the highest tertile ( p (interaction) < 0.001). Among participants from the lowest tertile of CRP levels, those with a high apoE levels had a significantly steeper increase in CRP than those with low apoE levels ( p = 0.020). Similar cardiovascular mortality risks as in ɛ3ɛ3 participants were found in ɛ2 and ɛ4 carriers. CONCLUSIONS: In old age, high plasma apoE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality, independent of APOE genotype and plasma lipids. Public Library of Science 2006-06 2006-05-09 /pmc/articles/PMC1457005/ /pubmed/16671834 http://dx.doi.org/10.1371/journal.pmed.0030176 Text en Copyright: © 2006 Mooijaart et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Mooijaart, Simon P Berbée, Jimmy F. P van Heemst, Diana Havekes, Louis M de Craen, Anton J. M Slagboom, P. Eline Rensen, Patrick C. N Westendorp, Rudi G. J ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title | ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title_full | ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title_fullStr | ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title_full_unstemmed | ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title_short | ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age |
title_sort | apoe plasma levels and risk of cardiovascular mortality in old age |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1457005/ https://www.ncbi.nlm.nih.gov/pubmed/16671834 http://dx.doi.org/10.1371/journal.pmed.0030176 |
work_keys_str_mv | AT mooijaartsimonp apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT berbeejimmyfp apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT vanheemstdiana apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT havekeslouism apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT decraenantonjm apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT slagboompeline apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT rensenpatrickcn apoeplasmalevelsandriskofcardiovascularmortalityinoldage AT westendorprudigj apoeplasmalevelsandriskofcardiovascularmortalityinoldage |